Jaguar Health Inc (NASDAQ:JAGX)’s share price traded down 4.2% during mid-day trading on Monday . The stock traded as low as $0.23 and last traded at $0.23. 70,503 shares were traded during mid-day trading, a decline of 100% from the average session volume of 18,383,772 shares. The stock had previously closed at $0.24.

Separately, ValuEngine downgraded Jaguar Health from a “buy” rating to a “hold” rating in a research report on Thursday, January 24th.

The company has a debt-to-equity ratio of 1.03, a current ratio of 0.46 and a quick ratio of 0.31.

COPYRIGHT VIOLATION WARNING: “Jaguar Health (JAGX) Trading Down 4.2%” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this story can be read at

Jaguar Health Company Profile (NASDAQ:JAGX)

Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

See Also: Trading signals using Bollinger bands

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with's FREE daily email newsletter.